Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Systemic Infection
Interventions
DRUG

Antibiotic

Ticarcillin-clavulanate/Timentin is an antibiotic used to treat a wide variety of bacterial infections. Rifampin/Rifadin/Rimatane is an antibiotic and first line antituberculotic. Clindamycin/Cleocin is an antibiotic used to treat a wide variety of bacterial infections and serious bacterial infections.

Trial Locations (10)

11203

Kings County Hospital Center, Brooklyn

27705

Duke University, Durham

30322

Emory University, Atlanta

32209

UFL Health and Baptist, Jacksonville

32610

University of FL, Gainesville

40202

University of Louisville, Louisville

46202

Indiana University, Indianapolis

67214

Wesley Medical, Wichita

77555

University of Texas Children's Hospital, Galveston

02111

Tufts Medical Center, Boston

All Listed Sponsors
lead

Phillip Brian Smith

OTHER

NCT01728363 - Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio) | Biotech Hunter | Biotech Hunter